HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCA – Research Report) and Danaher (...

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Danaher (DHR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCA – Research Report) and Viridian ...

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Viridian Therapeutics (VRDN)

RBC Capital analyst Ben Hendrix maintained a Buy rating on HCA Healthcare yesterday and set a price target of $555.00. The company’s shares closed ...

RBC Capital Remains a Buy on HCA Healthcare (HCA)

In a report released yesterday, Jason Cassorla from Guggenheim maintained a Hold rating on HCA Healthcare. The company’s shares closed yesterday at...

Guggenheim Sticks to Their Hold Rating for HCA Healthcare (HCA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on UnitedHealth (UNH – Research Report), HCA Healthcare...

Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), HCA Healthcare (HCA) and Cardiff Oncology (CRDF)

KeyBanc analyst Matthew Gillmor CFA maintained a Buy rating on HCA Healthcare today and set a price target of $550.00. Gillmor CFA covers the Healt...

HCA Healthcare (HCA) Gets a Buy from KeyBanc

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elicio Therapeutics (ELTX – Research Report) and HCA...

Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), HCA Healthcare (HCA)

In a report released today, Lance Wilkes from Bernstein maintained a Hold rating on HCA Healthcare, with a price target of $503.00. According to Ti...

HCA Healthcare (HCA) Receives a Hold from Bernstein

U.S. stocks finished the week mixed as gains in technology shares helped offset weakness in financial stocks and rising rate pressure. The Dow Jone...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 25

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on HCA Healthcare, with a price target of $525.00. Hendrix cov...

RBC Capital Sticks to Their Buy Rating for HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Simulations Plus (SLP – Research Report), DENTSPLY SIRONA (XRAY –...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Simulations Plus (SLP), DENTSPLY SIRONA (XRAY) and HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and HCA Healthcare (HCA – Re...

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and HCA Healthcare (HCA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on HCA Healthcare (HCA – Research Report), Vertex Pharmaceuticals (V...

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX) and Roche Holding AG (OtherRHHVF)

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Health Catalyst today and set a price target of $3.00. According to TipRank...

Evercore ISI Remains a Hold on Health Catalyst (HCAT)

In a report released today, David Grossman from Stifel Nicolaus maintained a Hold rating on Health Catalyst, with a price target of $3.75. Accordin...

Stifel Nicolaus Keeps Their Hold Rating on Health Catalyst (HCAT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ultragenyx Pharmaceutical (RARE – Research Report), ...

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Dexcom (DXCM) and Health Catalyst (HCAT)

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on HCA Healthcare, with a price target of $490.00. Langston covers ...

TD Cowen Keeps Their Buy Rating on HCA Healthcare (HCA)

In a report released today, Lance Wilkes from Bernstein maintained a Hold rating on HCA Healthcare, with a price target of $503.00. Wilkes covers t...

Bernstein Sticks to Its Hold Rating for HCA Healthcare (HCA)

HCA Healthcare received a Sell rating and a $425.00 price target from Morgan Stanley analyst Craig Hettenbach today. According to TipRanks, Hettenb...

HCA Healthcare (HCA) was downgraded to a Sell Rating at Morgan Stanley

Stifel Nicolaus analyst David Grossman maintained a Hold rating on Health Catalyst on January 2 and set a price target of $3.50. The company’s shar...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HCA	$496.85	+1.76%	954.04K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HCA	$496.85	+1.8%	954.04K
3
4
5
6

HCA

HCA

No Data Available

Get HCA Healthcare Inc. Data in Excel

Get HCA Healthcare Inc. Data in Excel